These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32276647)

  • 21. [Prevention of HIV-associated opportunistic infections].
    Gazzard BG
    Internist (Berl); 1994 Oct; 35(10):901-5. PubMed ID: 8002224
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of antiretroviral treatment and prophylaxis for opportunistic infections on survival of patients with AIDS].
    Gálvez Hermoso C; Blanco Quintana F; del Amo Valero J; Díez Ruiz-Navarro M; Soriano Vázquez V; González Lahoz J
    Rev Clin Esp; 2000 Apr; 200(4):187-92. PubMed ID: 10857401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India.
    Sharma SK; Kadhiravan T; Banga A; Goyal T; Bhatia I; Saha PK
    BMC Infect Dis; 2004 Nov; 4():52. PubMed ID: 15555069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Secondary diseases in patients with HIV infection: 15-year follow-up].
    Ermak TN; Kravchenko AV; Gruzdev BM
    Ter Arkh; 2004; 76(4):18-20. PubMed ID: 15174314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Overview of infectious and non-infectious diseases in French Guiana in 2022].
    Epelboin L; Abboud P; Abdelmoumen K; About F; Adenis A; Blaise T; Blaizot R; Bonifay T; Bourne-Watrin M; Boutrou M; Carles G; Carlier PY; Carod JF; Carvalho L; Couppié P; De Toffol B; Delon F; Demar M; Destoop J; Douine M; Droz JP; Elenga N; Enfissi A; Franck YK; Fremery A; Gaillet M; Kallel H; Kpangon AA; Lavergne A; Le Turnier P; Maisonobe L; Michaud C; Mutricy R; Nacher M; Naldjinan-Kodbaye R; Oberlis M; Odonne G; Osei L; Pujo J; Rabier S; Roman-Laverdure B; Rousseau C; Rousset D; Sabbah N; Sainte-Rose V; Schaub R; Sylla K; Tareau MA; Tertre V; Thorey C; Vialette V; Walter G; Zappa M; Djossou F; Vignier N
    Med Trop Sante Int; 2023 Mar; 3(1):. PubMed ID: 37389381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Causes of death among HIV infected adults in French Guyana and the French West Indies in the era of highly active antiretroviral therapy (HAART)].
    Lewden C; Sobesky M; Cabié A; Couppié P; Boulard F; Bissuel F; May T; Morlat P; Chêne G; Lamaury I; Salmon D;
    Med Mal Infect; 2004 Jul; 34(7):286-92. PubMed ID: 15679232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.
    Blanc FX; Badje AD; Bonnet M; Gabillard D; Messou E; Muzoora C; Samreth S; Nguyen BD; Borand L; Domergue A; Rapoud D; Natukunda N; Thai S; Juchet S; Eholié SP; Lawn SD; Domoua SK; Anglaret X; Laureillard D;
    N Engl J Med; 2020 Jun; 382(25):2397-2410. PubMed ID: 32558469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala.
    Samayoa B; Roy M; Cleveland AA; Medina N; Lau-Bonilla D; Scheel CM; Gomez BL; Chiller T; Arathoon E
    Am J Trop Med Hyg; 2017 Jul; 97(1):42-48. PubMed ID: 28719316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired immunodeficiency syndrome-related oral and/or cutaneous histoplasmosis: a descriptive and comparative study of 21 cases in French Guiana.
    Couppié P; Clyti E; Nacher M; Aznar C; Sainte-Marie D; Carme B; Pradinaud R
    Int J Dermatol; 2002 Sep; 41(9):571-6. PubMed ID: 12358826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-associated histoplasmosis in French Guiana: recent infection or reactivation?
    Hanf M; Adenis A; Couppie P; Carme B; Nacher M
    AIDS; 2010 Jul; 24(11):1777-8. PubMed ID: 20453632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013).
    Agbor AA; Bigna JJ; Billong SC; Tejiokem MC; Ekali GL; Plottel CS; Noubiap JJ; Abessolo H; Toby R; Koulla-Shiro S
    PLoS One; 2014; 9(12):e115211. PubMed ID: 25506830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Survival of patients with HIV-related tuberculosis. Study of mortality during the first 9 months of treatment].
    Falqués Casanovas M; Langohr K; Gómez Melis G; García de Olalla Rizo P; Jansà López del Vallado JM; Caylà Buqueras JA
    Rev Esp Salud Publica; 1999; 73(5):549-62. PubMed ID: 10650746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.
    Kingkaew N; Sangtong B; Amnuaiphon W; Jongpaibulpatana J; Mankatittham W; Akksilp S; Sirinak C; Nateniyom S; Burapat C; Kittikraisak W; Monkongdee P; Varma JK
    Int J Infect Dis; 2009 Nov; 13(6):722-9. PubMed ID: 19196530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Disseminated histoplasmosis: 2 cases in patients with human immunodeficiency virus infection in French Guiana].
    Gérard Y; Couppié P; del Giudice P; Mille H; Cuchet T; Sainte-Marie D; Pradinaud R
    Rev Med Interne; 1995; 16(10):767-70. PubMed ID: 8525157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm
    Mutembo S; Mutanga JN; Musokotwane K; Alisheke L; Whalen CC
    BMC Infect Dis; 2016 Oct; 16(1):572. PubMed ID: 27751168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
    Gordin F; Chaisson RE; Matts JP; Miller C; de Lourdes Garcia M; Hafner R; Valdespino JL; Coberly J; Schechter M; Klukowicz AJ; Barry MA; O'Brien RJ
    JAMA; 2000 Mar; 283(11):1445-50. PubMed ID: 10732934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of diagnostic methods and results for HIV-associated disseminated histoplasmosis: Pathologists are not sufficiently involved.
    Nacher M; Valdes A; Adenis A; Blaizot R; Ugo F; Abboud P; Demar M; Djossou F; Epelboin L; Misslin C; Blanchet D; Couppié P; Alsibai KD
    Trop Med Int Health; 2021 Nov; 26(11):1462-1469. PubMed ID: 34310800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Disseminated Histoplasmosis with and without Cutaneo-Mucous Lesions in Persons Living with HIV in French Guiana.
    Morote S; Nacher M; Blaizot R; Ntab B; Blanchet D; Drak Alsibai K; Demar M; Djossou F; Couppié P; Adenis A
    J Fungi (Basel); 2020 Aug; 6(3):. PubMed ID: 32806526
    [No Abstract]   [Full Text] [Related]  

  • 39. Disseminated histoplasmosis in HIV-infected patients: determinants of relapse and mortality in a north-eastern area of Brazil.
    Damasceno LS; Ramos AN; Alencar CH; Gonçalves MV; de Mesquita JR; Soares AT; Coutinho AG; Dantas CC; Leitão Tdo M
    Mycoses; 2014 Jul; 57(7):406-13. PubMed ID: 24612078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progression.
    Rabaud C; Charreau I; Izard S; Raffi F; Meiffredy V; Leport C; Guillemin F; Yeni P; Aboulker JP;
    Scand J Infect Dis; 2001; 33(10):759-64. PubMed ID: 11728044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.